Evidence map›Paper›PMID 42260099›Full record

ArticleNPJ precision oncology2026

Deep learning-based spatiotemporal estimation of lesion changes for patient-level assessment of breast cancer lung metastases on longitudinal CT.

Jialin Shi, Yali Xu, Zhixian Chen, Ji Wu, Ning Ding, Xiaoping Yi, Feifei Wu, Xiaohong Yang, Yue Shi, Tingzi Yang and 7 more

Abstract read
In one paragraph

Article in NPJ precision oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Jialin ShiSchool of Computer and Communication Engineering, University of Science and Technology Beijing, Beijing, China.
Yali XuDepartment of Breast Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, Beijing, China.
Zhixian ChenSchool of Computer and Communication Engineering, University of Science and Technology Beijing, Beijing, China.
Ji WuDepartment of Electronic Engineering, Tsinghua University, Beijing, Beijing, China.
Ning DingDepartment of Radiology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, Beijing, China.
Xiaoping YiDepartment of Radiology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Feifei WuDepartment of Radiology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Xiaohong YangDepartment of Breast Diseases, Shanxi Provincial Hospital of Traditional Chinese Medicine, Taiyuan, Shanxi, China.
Yue ShiDepartment of Breast Diseases, Shanxi Provincial Hospital of Traditional Chinese Medicine, Taiyuan, Shanxi, China.
Tingzi YangDepartment of Breast Diseases, Shanxi Provincial Hospital of Traditional Chinese Medicine, Taiyuan, Shanxi, China.
He ShiDepartment of Breast Diseases, Shanxi Provincial Hospital of Traditional Chinese Medicine, Taiyuan, Shanxi, China.
Junqing LiangDepartment of Breast Oncology, Peking University Cancer Hospital Inner Mongolia Hospital, Saihan District, Hohhot, China.
Yanan WangDepartment of Breast Oncology, Peking University Cancer Hospital Inner Mongolia Hospital, Saihan District, Hohhot, China.
Tianyu RuanDepartment of Breast and Thyroid Surgery, Liuzhou People's Hospital, Liuzhou, Guangxi, China.
Yiming CaoDepartment of Radiology, Liuzhou People's Hospital, Liuzhou, Guangxi, China.
Qiang SunDepartment of Breast Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, Beijing, China.
Lingyan KongDepartment of Radiology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, Beijing, China. klyan@163.com.

Funding

CAMS Innovation Fund for Medical Sciences (CIFMS) 2021-I2M-1-014Guangdong Basic and Applied Basic Research Foundation 2023A1515110721Noncommunicable Chronic Diseases-National Science and Technology Major Project 2023ZD0506502The Key Research and Development Program of NingXia 2023BEG02060
6 · The paper itself

Abstract

Clinical management of breast cancer lung metastasis is challenging because of the complexity of dynamic lesion assessment. Traditional methods based on RECIST1.1 rely on size measurement, and existing studies require image registration and are limited to lesion-level assessment. In this study, we proposed a patient-level spatiotemporal assessment framework without registration to comprehensively analyze multiple lesions evolvement based on longitudinal CT images. Our method considers metastatic lesions that vary in size and often overlap with complex structures such as blood vessels and bones, and avoids potential registration errors. Our method outperforms state-of-the-art methods on both the Peking Union Medical College Hospital breast cancer lung metastasis dataset and the publicly available dataset. The model also showed excellent performance in a multicenter validation across four medical centers. We established a patient-level metastatic breast cancer assessment framework, providing a practical solution for longitudinal treatment monitoring.

Identifiers

PMID42260099
PMCPMC13578422

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.